Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and cancer center visits.

Jump to a Topic:

Doctors at Henry Ford Hospital

Henry Ford Offers Excellence in Care

The Henry Ford Cancer Institute boasts an elite program that combines multidisciplinary expertise with experience, training and research for a wide range of malignancies, including mesothelioma.

Teamwork across all disciplines is what enables the staff to consistently deliver exceptional care.

Henry Ford has 17 multidisciplinary tumor boards serving patients. It is the only cancer center in the state of Michigan to receive the prestigious Outstanding Achievement Award for 2019 by the Commission on Cancer.

The institute treats more than 9,500 new cancer patients every year, taking them from diagnosis to survivorship and assisting them at every step in between.

Henry Ford has been recognized for excellence in six major categories. They include:

  • Chemotherapy and medical oncology

  • Cancer surgery

  • Radiation therapy

  • Cancer support services

  • Clinical trials

  • Precision medicine

The staff is spread across five hospitals and several outpatient locations throughout south central and southeast Michigan. Henry Ford Hospital in Detroit is the flagship. It is nationally recognized for its innovative treatment of several cancers, including thoracic and lung cancers.

On that hospital campus today is the Brigitte Harris Cancer Pavilion, which opened in the summer of 2020. It now serves as a world-class, state-of-the-art facility and is a hub for the five area hospitals.

As a destination cancer center, Henry Ford has treated patients from all 50 states over the last decade.

Find More Top Mesothelioma Cancer Centers

Treating Mesothelioma at Henry Ford Cancer Institute

Pleural and peritoneal mesothelioma — both rare cancers — are treated effectively at Henry Ford with a personalized, multidisciplinary approach.

Henry Ford is one of a handful of specialty centers in the country offering the combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, also known as HIPEC, for peritoneal mesothelioma and several other abdominal cancers.

This combination treatment has dramatically increased survival for peritoneal patients, many of whom are now living five to 10 years and beyond their original diagnosis.

The thoracic and lung cancer team uses a multidisciplinary approach when it comes to treating pleural mesothelioma, which may include chemotherapy, radiation, surgery and a novel targeted therapy that stops the growth of blood vessels feeding tumors.

Henry Ford’s pleural mesothelioma team includes thoracic surgeon Dr. Raed Alnajjar, thoracic oncologist Dr. Shirish Gadgeel and radiation oncologist Dr. Munther Ajlouni.

Doctor talking to patients

Connect with a Top Mesothelioma Doctor

We've helped thousands of people affected by mesothelioma find the best treatments.

Get Started Now

Henry Ford Cancer Institute Practices Precision Medicine

Henry Ford Cancer Institute’s Precision Medicine Program is the most comprehensive in Michigan.

The program is designed to better personalize treatment by using genomic testing of tumors and the expertise of its molecular tumor board for every patient it serves.

Their plan involves individualizing each patient’s cancer profile based on inherited genetic traits, past environmental influences and lifestyle differences.

Precision medicine allows doctors to better identify treatments and novel drugs that will be the most effective for each patient, based upon the genetic traits that may influence the individual cancer.

Mesothelioma Clinical Trials at Henry Ford Cancer Institute

  • A phase II clinical trial studying the effectiveness of an immunotherapy combination involving nivolumab (Opdivo) and ipilimumab (Yervoy) for rare tumors, including mesothelioma.

  • A phase II clinical trial for pleural mesothelioma involving the use of the drug ADI-PEG20, an enzyme designed to restrict the amino acid arginine, which helps fuel tumor growth.

  • A phase I clinical trial studying the use of atezolizumab, an immunotherapy drug, in combination with surgery and chemotherapy, either with or without radiation treatment. Atezolizumab can be used both before and after surgery.

Get Help Enrolling in a Mesothelioma Clinical Trial

Disclaimer: Henry Ford Hospital has no professional affiliation with Asbestos.com.

Stethoscope Icon
Get Help Contacting this Cancer Center

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get Free Recipes for Mesothelioma Patients

Get Your Guide
Asbestos.com Mesothelioma Packet

Get the Top Mesothelioma Guide for Free

Get Yours Now

Get the Compensation You Deserve

Find an Attorney

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. The Henry Ford Cancer Institute. (n.d.). One-of-a-kind advanced and personally crafted cancer treatment. Retrieved from: https://www.henryford.com/services/cancer
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified December 8, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now